Opthea to Present at the OIS Retina Innovation Summit at ARVO

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

Opthea (ASX/NASDAQ: OPT) will present at the OIS Retina Innovation Summit at ARVO. Dr. Frederic Guerard, CEO, will discuss the company's clinical-stage pipeline and innovation agenda on May 4, 2024, in Seattle, Washington.

MELBOURNE, Australia and PRINCETON, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration, today announced that Dr. Frederic Guerard, Chief Executive Officer (CEO) of Opthea, will present the Company’s clinical-stage pipeline, as well as its innovation agenda, at the OIS Retina Innovation Summit prior to the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting on May 4, 2024 in Seattle, Washington.

OIS Retina Innovation Summit Details

Session	Innovation Showcase
Date:	Saturday, May 4, 2024
Time:	8:35 to 9:50 a.m. PDT
Presenter:	Frederic Guerard, PharmD, CEO

About Opthea

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).

Opthea’s lead product candidate, sozinibercept, is being evaluated in two pivotal Phase 3 clinical trials (COAST, NCT04757636, and ShORe, NCT04757610) for use in combination with standard-of-care anti-VEGF-A monotherapies to improve overall efficacy and deliver superior vision gains compared to standard-of-care anti-VEGF-A agents. To learn more, visit our website and follow us on X and LinkedIn. 

Authorized for release to ASX by Frederic Guerard, CEO 

Investor Inquiries

PJ Kelleher 
LifeSci Advisors, LLC 
Email: pkelleher@lifesciadvisors.com
Phone: 617-430-7579 

Media Inquiries 

Silvana Guerci-Lena 
NorthStream Global Partners 
silvana@nsgpllc.com 

Join our email database to receive program updates:  
Tel: +61 (0) 3 9826 0399, Email: info@opthea.com Web: www.opthea.com   

FAQ

When will Opthea present at the OIS Retina Innovation Summit?

Opthea will present at the OIS Retina Innovation Summit on May 4, 2024.

What is the focus of Opthea's presentation at the summit?

Opthea will discuss its clinical-stage pipeline and innovation agenda at the summit.

Who will be presenting for Opthea at the OIS Retina Innovation Summit?

Dr. Frederic Guerard, CEO of Opthea, will be presenting at the OIS Retina Innovation Summit.

Where will the OIS Retina Innovation Summit take place?

The OIS Retina Innovation Summit will take place in Seattle, Washington.